Biologics Development and Manufacturing Testing: Technologies and Global Markets

Report Code: BIO155B

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.

Report Includes

  • 13 data tables and 16 additional tables
  • An up-to-date review and analysis of the global markets for biological safety testing and related technologies
  • Analyses of the global market trends, with market revenue data for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion of market dynamics that impact the growth for biologics development and manufacturing testing, clinical applications, safety regulations, industry structure, and penetration of technologies within the biotech industry
  • Coverage of the technological, economic, and business considerations of global biological safety testing market, with analyses and growth forecasts through 2027
  • Estimation of the actual market size and revenue forecast for global biological safety testing market in USD million values, and corresponding market share analysis based on test type, application, technology, and region
  • Identification of the companies best positioned to meet the increasing demand for biological safety testing owing to their proprietary technologies, product launches, mergers and acquisitions, and other strategic advantages
  • Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the market leading players, including Catalent, Eurofins Scientific, Lonza, Merck, Thermo Fisher Scientific and WuXi AppTec

Report Scope

This report aims to provide a comprehensive study of the global market for biologics safety testing, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding biologics safety testing products and services. Biologics safety testing includes biosafety testing & characterization of raw materials, cell bank & virus seeds, unprocessed bulks/viral harvests, and drug substance/product.

This report segments the global biologics safety testing market by application, test application, testing technology, and region of operations. BCC Research analyses each market and its applications, regulatory environments, technology, market projections, and market share. Industry growth drivers, restraints, trends, and opportunities in the biological safety testing market are also discussed in detail. The report also provides information on the competitive landscape, elaborate company profiles, and the impact of COVID-19 on the biologics safety testing market.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $6.2 billion
Market size forecast $18.2 billion
Growth rate CAGR of 19.9% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered application, test application, testing technology, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered United States, Canada, France, Germany, Italy, Spain, United Kingdom, China, Japan, India, Latin America, Middle East, and Africa
Key Market Drivers
  • Significant Growth in Biologics Market
  • The Need for Speed to Market
  • Significant Demand for Cell and Gene Therapy Testing Services
  • Continuous Growth in Biotechnology Industry
  • Accelerating Biosimilars and Biobetters Market
Companies studied
AVANCE BIOSCIENCESBSL BIOSERVICE SCIENTIFIC LABORATORIES MUNICH GMBH
CATALENT INC.CHARLES RIVER LABORATORIES
CYTOVANCE BIOLOGICSEUROFINS SCIENTIFIC
INTERTEK GROUP PLCLABORATORY CORPORATION OF AMERICA HOLDINGS
LONZAMERCK KGAA
SARTORIUS AGSGS SA
THERMO FISHER SCIENTIFIC INC.WUXI APPTEC
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global biologics safety testing market is projected to grow from $7.4 billion in 2022 to $18.2 billion in 2027, at a compound annual growth rate (CAGR) of 19.9% during the forecast period.
The global biologics safety testing market is estimated to grow at a rapid rate through 2022 to 2027 based upon a number of factors including: 1) The anticipated number of new and complex biologics that are likely to be approved for commercial use; 2) The anticipated growth in the generic biosimilars market; and 3) the increasing number of biosimilars that will be manufactured overseas (especially by CMO’s located in Asia). With a rising number of approved biological products as well as an increasing variety of therapy types and substance classes coupled with growing demand for biologics, the biologics commercial production and lot release testing market is expected to grow at the fastest rate during the forecast period.
The biologics safety testing is segmented based on test objective, test type, test technology type, and region.
Biosafety testing will dominate the market by the end of 2027.
Key companies in the market includes Charles River Laboratories International Inc. (U.S.), ThermoFisher Scientific (U.S.), WuXi AppTec (China), SGS S.A. (Switzerland), Merck KGaA (Germany), and Labcorp. (U.S.)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biologics Development and Manufacturing Testing: Technologies and Global Markets123Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market and Technology Background6Free
Chapter- 4: Market Dynamics 13Free
Chapter- 5: Impact of the COVID-19 Pandemic4Free
Chapter- 6: Market Breakdown by Application Type16Free
Chapter- 7: Market Breakdown by Type of Test16Free
Chapter- 8: Market Breakdown by Technology 11Free
Chapter- 9: Market Breakdown by Region8Free
Chapter- 10: Competitive Landscape8Free
Chapter- 11: Company Profiles32Free

Related Reports

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

2024 Cell and Gene: Research Review

Published - Apr 2025 | Publisher - Various Analysts | Code - BIO267A

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.

Biosimilars: Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - BIO090E

The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Mar 2025 | Publisher - BCC Publishing | Code - BIO014M

The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 29

  • Summary Table: Global Market for Biologics Safety Testing, by Application Type, Through 2027
  • Table 1: Definition of Biologics
  • Table 2: Biological Products or Biologics Safety Testing, by Drug Development Phase
  • Table 3: Global Market for Protein Drugs, Through 2026
  • Table 4: Global Pipeline Molecules, by Type, Through 2021
  • Table 5: Biotech Funding (Capital Markets/IPOs/VCs), 2005-09 vs. 2020
  • Table 6: Global Healthcare R&D Expenditure Growth, by Pharma Size, 2017-2025E*
  • Table 7: Key Trends in In Vivo Based Testing
  • Table 8: Key Trends in Cell-Based In Vitro Safety Testing
  • Table 9: Key Trends in Analytical Testing Services
  • Table 10: Total Number of COVID-19 Confirmed Cases and Deaths, by Region, June 2022
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Published - Mar-2018| Analyst - David Peters| Code - BIO155A

Report Highlights

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Report Includes 

  • An overview of the global market for biological safety testing and related technologies.
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of the latest market trends, regulatory environments, market projections, and market share.
  • A look at future of biological patents and biosimilars along with biologics patents by year.
  • Company profiles of major players in the industry, including Charles River Laboratories, WuXi AppTec, SGS SA, Thermo Fisher Scientific and Lonza Group.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biologics Development and Manufacturing Testing: Technologies and Global Markets
Customize Report